Latest gabapentin Stories
Most anti-epileptic drugs are associated with an increased risk of non-traumatic fracture in individuals 50 years of age and older.
KANSAS CITY, Mo., Nov. 17, 2010 /PRNewswire/ -- Teva Neuroscience today announced the addition of an 11th member to Team COPAXONEÂ® (glatiramer acetate injection); continuing a year-long celebration of the Team's 10 years of advocacy within the multiple sclerosis (MS) community.
BURLINGTON, Mass., Oct. 6 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, although NeurogesX/Astellas's Qutenza is only approved for postherpetic neuralgia, surveyed U.S.
While the Food and Drug Administration (FDA) requires a warning of an increased risk of suicide for all epilepsy drugs, a new study shows that only certain drugs may increase the risk.
For patients with quadriplegia, mutism and lower cranial nerve paralysis (locked-in syndrome), their only means of interacting with others is through vertical gaze and upper eyelid movements, using eye-coded communication strategies.
PITTSBURGH, June 4 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S.
MELBOURNE, Australia and SAN FRANCISCO, May 28 /PRNewswire/ -- Relevare Pharmaceuticals Ltd.
NEW YORK, May 17 /PRNewswire-FirstCall/ -- In a first-of-a-kind collaboration between academia and industry, Pfizer Inc. (NYSE: PFE) will give scientists at Washington University School of Medicine in St.
NEW YORK, March 25 /PRNewswire/ -- Following a month-long trial in United States District Court in Boston, a federal jury awarded Plaintiffs Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals over $47 million in damages, before mandatory trebling and interest.
WALTHAM, Mass., March 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a novel formulation of Pfizer's Neurontin that is dosed once a day would earn a 50 percent patient share in the treatment of postherpetic neuralgia, according to surveyed U.S.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.